Depakote Attorneys
Depakote (divalproex sodium) was manufactured by Abbott Laboratories and was first approved by the Food & Drug Administration (FDA) in 1978 for the treatment of epilepsy. Most recently, the drug has been approved for the treatment of seizure disorders, certain psychiatric conditions (manic phase of bipolar disorder), and to prevent migraine headaches. The drug works by restoring the balance of certain natural substances (neurotransmitters) in the brain.